Skip to main content

Table 3 Potential active components in FM-RC

From: Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology

Number

Molecular name

(OB)%

DL

Attribute

WM1

(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one

42.36

0.21

FM

WM2

beta-sitosterol

36.91

0.75

FM

WM3

kaempferol

41.88

0.24

FM

WM4

stigmasterol

43.83

0.76

FM

WM5

methyl arachidonate

46.9

0.23

FM

WMHL

quercetin

46.43

0.28

FM,RC

HL1

berberine

36.86

0.78

RC

HL2

obacunone

43.29

0.77

RC

HL3

berberrubine

35.74

0.73

RC

HL4

epiberberine

43.09

0.78

RC

HL5

(R)-Canadine

55.37

0.77

RC

HL6

berlambine

36.68

0.82

RC

HL7

palmidin A

35.36

0.65

RC

HL8

palmatine

64.60

0.65

RC

HL9

coptisine

30.67

0.86

RC

HL10

worenine

45.83

0.87

RC

HL11

moupinamide

86.71

0.26

RC

HL12

corchoroside A_qt

104.95

0.78

RC

  1. Abbreviations: FM Fructus Mume, RC Rhizoma Coptidis